CVE-2026-21970

CVE-2026-21970 is a medium-severity vulnerability in Oracle Life Sciences Central Designer with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N).

Frequently asked questions

What is CVE-2026-21970?
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N).
How severe is CVE-2026-21970?
CVE-2026-21970 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2026-21970 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (16th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-21970?
CVE-2026-21970 affects Oracle Life Sciences Central Designer. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2026-21970?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2026-21970 have an EU (EUVD) identifier?
Yes. CVE-2026-21970 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2026-3542.
When was CVE-2026-21970 published?
CVE-2026-21970 was published on 2026-01-20 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Oracle Life Sciences Central Designer

All CVEs affecting Oracle Life Sciences Central Designer →